Tg Therapeutics (TGTX) Stock Price, Quote & News

Company Profile

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's de...

Industry: Biotechnology

Sector: Healthcare

Phone: 212 554 4484

Fax: 212 554 4531

Website: www.tgtherapeutics.com

Address:

3020 Carrington Mill Blvd., Suite 475, Morrisville, United States

NiceBuzz Jun. 27 at 3:54 AM

$TGTX What has happened recently that would make this a bo candidate? It’s only gotten more expensive. SubQ will happen for sure. Q2 will be good without a doubt and a raise. The question is nxpharm. People here can pretend like they have answers like they did with iova or alt, but no one knows. TG will be fine in the long run, but be cautious of these echo chambers.

0 · Reply

Buyaa Jun. 27 at 1:53 AM

$TGTX - Something deep tells me we have 4 weeks to buy back Neuraxpharm rights and 1 week for the 4th of July fireworks 💥. If we’re to guess the fireworks for TGTX will most likely happen this weekend with the BO above $70. This will leave few weeks for the counter bid till end of July from other companies. Also in July most likely we will have interest rates fall as well, which will be huge for Pharma / Bio Tech space for a buy out above $10 B offer. Watch out for Novartis or Pfizer or some big pharma to come and scoop out TGTX this weekend. It’s happening soon . 🎉🎊🚀💪🙏

1 · Reply

PotionX1900 Jun. 27 at 12:26 AM

$TGTX We're going to climb this thing back to $40+ right here. It's going to take some grinding and turning to do it. I'm willing to bet it's going to happen.

1 · Reply

CedarPark Jun. 27 at 12:24 AM

$TGTX solid day with good finish again, looking bullish :)

0 · Reply

Quad_ Jun. 26 at 10:29 PM

$TGTX $104.44. That's my final offer.

2 · Reply

Idvst8 Jun. 26 at 9:50 PM

$TGTX - solid Finish

0 · Reply

Luckybreak Jun. 26 at 9:42 PM

$TGTX In future if certain # is hit MW gets $16 million in bonus . He is going to be a billionaire soon .At 6% On a billion he will make $60 million in interest income (6 % ) each and every year absolutely doing nothing if he wants to .Why would he care for $16 in bonus . Good problem to have !! TGTX will be history before 2026 and possibly by end of July .

1 · Reply

jmartin795 Jun. 26 at 9:16 PM

$TGTX very nice close today

0 · Reply

ern1in Jun. 26 at 9:01 PM

$TGTX These ribs ..... are in trouble !!!!

0 · Reply

ern1in Jun. 26 at 8:45 PM

$TGTX THAT TIME ...... DAMN IT ! 😝😝😝😝😝😝😝😝😝😝😝

0 · Reply

TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel

Jun 9, 2025, 4:51 PM EDT - 17 days ago

Evercore ISI's Julian Emanuel says now is the time to buy small-caps

CNS LEU RMBS SFM

Jun 6, 2025, 7:30 AM EDT - 20 days ago

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 6:00 AM EDT - 4 weeks ago

TG Therapeutics: Estimates Could Soon Be Raised Again

May 27, 2025, 7:30 AM EDT - 4 weeks ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting

May 5, 2025, 4:37 PM EDT - 7 weeks ago

TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show

May 5, 2025, 1:30 PM EDT - 7 weeks ago

TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges

May 5, 2025, 10:55 AM EDT - 7 weeks ago

TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript

May 5, 2025, 7:00 AM EDT - 7 weeks ago

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

Apr 30, 2025, 7:30 AM EDT - 2 months ago

TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update

Apr 10, 2025, 7:30 AM EDT - 2 months ago

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Apr 7, 2025, 7:30 AM EDT - 2 months ago

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

Mar 21, 2025, 11:50 AM EDT - 3 months ago

Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher

Mar 15, 2025, 8:42 AM EDT - 3 months ago

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel

Mar 14, 2025, 2:04 PM EDT - 3 months ago

TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials

Mar 12, 2025, 4:11 PM EDT - 3 months ago

TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter

Mar 7, 2025, 7:30 AM EST - 3 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Mar 4, 2025, 7:03 AM EST - 4 months ago

Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025

CORT GILD PRVA TKO

Mar 3, 2025, 3:59 PM EST - 4 months ago

TG Therapeutics: A Wonderful Hold

Mar 3, 2025, 11:55 AM EST - 4 months ago

TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:30 AM EST - 4 months ago

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Feb 26, 2025, 7:30 AM EST - 4 months ago

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

Feb 18, 2025, 10:20 AM EST - 4 months ago

20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset'

ARWR AUB CRK CYTK EXE KRYS MARA

Jan 23, 2025, 2:48 PM EST - 5 months ago

TG Therapeutics: Entering 2025 With Increased Investor Expectations

Jan 21, 2025, 2:17 AM EST - 5 months ago

TG Therapeutics: 2025 Revenues Will Smash Expectations

Jan 13, 2025, 11:38 PM EST - 5 months ago

TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst

Jan 9, 2025, 7:30 AM EST - 6 months ago

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 4, 2024, 7:36 AM EST - 7 months ago

20 stocks likely to lag the S&P 500 over the next year — for this one reason

CELH CENX CNXC CRSR CXM FLG GEO

Nov 29, 2024, 8:00 AM EST - 7 months ago

TG Therapeutics to Participate in the Evercore HealthCONx Conference

Nov 21, 2024, 6:00 AM EST - 7 months ago

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Nov 5, 2024, 1:50 PM EST - 8 months ago

TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates

Nov 4, 2024, 8:27 PM EST - 8 months ago

TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here's Why Shares Fell

Nov 4, 2024, 11:16 AM EST - 8 months ago

TG Therapeutics, Inc. (TGTX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 9:00 AM EST - 8 months ago

FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics

Nov 1, 2024, 8:06 AM EDT - 8 months ago

TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

Sep 22, 2024, 8:17 AM EDT - 9 months ago

TG Therapeutics: A Look At New Briumvi Data And Ocrevus Zunovo Approval

Sep 18, 2024, 7:15 AM EDT - 10 months ago

New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis

Sep 18, 2024, 7:00 AM EDT - 10 months ago

New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment

Sep 5, 2024, 7:30 AM EDT - 10 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

Aug 7, 2024, 4:59 AM EDT - 11 months ago

TG Therapeutics Delivers A Beat-And-Raise Q2 And A $100 Million Buyback

Aug 6, 2024, 3:12 PM EDT - 11 months ago

TG Therapeutics, Inc. (TGTX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 9:01 AM EDT - 11 months ago

HealthCare Royalty and Blue Owl Announce $250M Debt Financing with TG Therapeutics

Aug 5, 2024, 7:30 AM EDT - 11 months ago

TG Therapeutics to Host Conference Call on Second Quarter 2024 Financial Results and Business Update

Jul 30, 2024, 5:00 AM EDT - 11 months ago

TG Therapeutics: Pressure On Briumvi To Perform As Share Price Hits Resistance

Jun 7, 2024, 7:50 AM EDT - 1 year ago

TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Jun 3, 2024, 7:30 AM EDT - 1 year ago

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

May 31, 2024, 7:30 AM EDT - 1 year ago

TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

May 28, 2024, 7:30 AM EDT - 1 year ago

TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

May 3, 2024, 9:53 AM EDT - 1 year ago

TG Therapeutics: Less Room For Doubt About Briumvi

May 2, 2024, 10:21 PM EDT - 1 year ago

TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript

NiceBuzz Jun. 27 at 3:54 AM

0 · Reply

Buyaa Jun. 27 at 1:53 AM

1 · Reply

PotionX1900 Jun. 27 at 12:26 AM

$TGTX We're going to climb this thing back to $40+ right here. It's going to take some grinding and turning to do it. I'm willing to bet it's going to happen.

1 · Reply

CedarPark Jun. 27 at 12:24 AM

$TGTX solid day with good finish again, looking bullish :)

0 · Reply

Quad_ Jun. 26 at 10:29 PM

$TGTX $104.44. That's my final offer.

2 · Reply

Idvst8 Jun. 26 at 9:50 PM

$TGTX - solid Finish

0 · Reply

Luckybreak Jun. 26 at 9:42 PM

1 · Reply

jmartin795 Jun. 26 at 9:16 PM

$TGTX very nice close today

0 · Reply

ern1in Jun. 26 at 9:01 PM

$TGTX These ribs ..... are in trouble !!!!

0 · Reply

ern1in Jun. 26 at 8:45 PM

$TGTX THAT TIME ...... DAMN IT ! 😝😝😝😝😝😝😝😝😝😝😝

0 · Reply

mauzy Jun. 26 at 8:36 PM

$TGTX Low volume day today. Nice to finish green. On to tomorrow

0 · Reply

Cedenmo Jun. 26 at 8:33 PM

$TGTX If you believe in Mike’s CEO ego, figure this should start touching $10B market cap around end of Feb 2026 if we’re still around. That coincides with the 61/120 $10B market cap timeline by June for $16M cash bonus. So somewhere $60-$65 depending on options, RSUs, etc.

0 · Reply

neilinva Jun. 26 at 8:20 PM

$TGTX My Boat is loaded!!!

0 · Reply